Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2019

Aug 14, 2019

SELL
$44.62 - $49.34 $20.1 Million - $22.2 Million
-450,000 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $20.3 Million - $24.2 Million
450,000 New
450,000 $21.5 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Hunting Hill Global Capital, LLC Portfolio

Follow Hunting Hill Global Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hunting Hill Global Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hunting Hill Global Capital, LLC with notifications on news.